Dr Jesse Goodman
Independent Non-Executive Director
Dr Jesse Goodman - download image (JPG)
Dr Goodman was appointed as an Independent Non-Executive Director on 1 January 2016.
Dr Goodman previously served in senior leadership positions at the US Food and Drug Administration (FDA), including most recently as the FDA’s Chief Scientist and previously as Deputy Commissioner for Science and Public Health and as Director of the Center for Biologics Evaluation and Research (CBER).
Dr Goodman played a leadership role in developing the FDA’s Regulatory Science and Medical Countermeasures Initiatives and has worked collaboratively with industry, academia, government and global public health and regulatory partners to prepare for and respond to major public health threats, including emerging infectious diseases, disasters and terrorism. He led the FDA’s response to West Nile Virus and to the 2009 H1N1 inﬂuenza pandemic and served on the Senior Leadership Team for the 2010 White House Medical Countermeasure Review. Dr Goodman brings scientiﬁc and public health expertise to the Board’s deliberations.
Dr Goodman, currently Professor of Medicine at Georgetown University, directs the Georgetown University Center on Medical Product Access, Safety and Stewardship (COMPASS) and is an active clinician who serves as Attending Physician in Infectious Diseases. He also serves as President and Member of the Board of the United States Pharmacopeia (USP), a member of the Regulatory Working Group of the Coalition for Epidemic Preparedness Innovations (CEPI) and of the US National Academy of Medicine. Dr Goodman is a member of the Board of Intellia Therapeutics, Inc, Cambridge, MA.
Find out more
Speeches & presentations
Search through our archive of speeches and presentations from conferences and events
Discover our latest financial performance announcement and search for historical quarterly results materials
Board of Directors
The Board of Directors is responsible for the group's system of corporate governance and is ultimately accountable for the group's activities, strategy, risk management and financial performance.
Corporate Executive Team
The Corporate Executive Team manages our activities, and each member is responsible for a specific part of the business